Company
Headquarters: Taoyuan City, Taiwan
TW$23.44 Billion
TWD as of July 1, 2025
US$800.4 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $193.76 B |
| EssilorLuxottica SA | $128.90 B |
| Becton, Dickinson and Company | $50.81 B |
| Alcon Inc. | $44.33 B |
| HOYA Corp | $40.30 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. The company was incorporated in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Pegatron Corp.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | TW$7.06 B |
| EBITDA | TW$3.13 B |
| Gross Profit TTM | TW$4.02 B |
| Profit Margin | 28.27% |
| Operating Margin | 28.31% |
| Quarterly Revenue Growth | -1.10% |
Pegavision Corp has the following listings and related stock indices.
Stock: TWSE: 6491 wb_incandescent